Cangrelor or Clopidogrel in Patients with Type 2 Diabetes Mellitus Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled Trials

被引：0
|
作者：
Hongtao Lu
Wenjun Guan
Yanhua Zhou
Zhangui Tang
Hong Bao
机构：
[1] Yangtze University,Jingzhou Central Hospital of Cardiology, The Second Clinical Medical College
[2] The First Affiliated Hospital of Yangtze University,Department of Hematology, Jingzhou First People’s Hospital
[3] Central South University,Institute of Cardiovascular Disease, Xiangya Hospital
[4] Jiangling County People’s Hospital of Cardiology,undefined
来源：
Diabetes Therapy | 2019年 / 10卷
关键词：
Antiplatelet agents; Cangrelor; Cardiovascular disease; Clopidogrel; Percutaneous coronary intervention; Type 2 diabetes mellitus;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：937 / 950
页数：13
相关论文
共 50 条
  • [1] Cangrelor or Clopidogrel in Patients with Type 2 Diabetes Mellitus Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled Trials
    Lu, Hongtao
    Guan, Wenjun
    Zhou, Yanhua
    Tang, Zhangui
    Bao, Hong
    [J]. DIABETES THERAPY, 2019, 10 (03) : 937 - 950
  • [2] Cangrelor for patients undergoing percutaneous coronary intervention: evidence from a meta-analysis of randomized trials
    Sardar, Partha
    Nairooz, Ramez
    Chatterjee, Saurav
    Mushiyev, Savi
    Pekler, Gerald
    Visco, Ferdinand
    [J]. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2014, 38 (01) : 1 - 10
  • [3] Cangrelor for patients undergoing percutaneous coronary intervention: evidence from a meta-analysis of randomized trials
    Partha Sardar
    Ramez Nairooz
    Saurav Chatterjee
    Savi Mushiyev
    Gerald Pekler
    Ferdinand Visco
    [J]. Journal of Thrombosis and Thrombolysis, 2014, 38 : 1 - 10
  • [4] Prasugrel versus clopidogrel in acute coronary syndrome patients undergoing percutaneous coronary intervention: A meta-analysis of randomized controlled trials
    张步春
    车文良
    刘伟静
    徐亚伟
    [J]. South China Journal of Cardiology, 2010, 11 (04) : 238 - 245
  • [5] Efficacy and safety of bivalirudin versus heparin in patients with diabetes mellitus undergoing percutaneous coronary intervention A meta-analysis of randomized controlled trials
    Zhang, Juan
    Yang, Xinchun
    [J]. MEDICINE, 2017, 96 (29)
  • [6] Efficacy and Safety of Ticagrelor in Diabetes Patients Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled Trials
    Zhang, Zeyi
    Chen, Ou
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2021, 77 (05) : 536 - 543
  • [7] Meta-Analysis of the Role of Cangrelor for Patients Undergoing Percutaneous Coronary Intervention
    Majmundar, Monil
    Kansara, Tikal
    Jain, Akash
    Shah, Palak
    Mithawala, Priyam
    Desai, Rupak
    Shah, Priyank
    Doshi, Rajkumar
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2019, 123 (07): : 1069 - 1075
  • [8] A network meta-analysis comparing cangrelor, prasugrel, ticagrelor, and clopidogrel in patients undergoing percutaneous coronary intervention
    Westman, P. C.
    Lipinski, M.
    Torguson, R.
    Waksman, R.
    [J]. EUROPEAN HEART JOURNAL, 2016, 37 : 385 - 386
  • [9] Coronary artery bypass grafting versus percutaneous coronary intervention in patients with noninsulin treated type 2 diabetes mellitus: A meta-analysis of randomized controlled trials
    Wang, Yushu
    Wen, Meiqin
    Zhou, Junteng
    Chen, Yucheng
    Zhang, Qing
    [J]. DIABETES-METABOLISM RESEARCH AND REVIEWS, 2018, 34 (01)
  • [10] Cangrelor Decreases Ischemia Driven Revascularization in Patients Undergoing Percutaneous Coronary Intervention: Evidence From a Meta-analysis of Randomized Trials
    Nairooz, Ramez
    Sardar, Partha
    Chatterjee, Suarav
    Mushiyev, Savi
    Pekler, Gerald
    Visco, Ferdinand
    [J]. CIRCULATION, 2013, 128 (22)
12345